Bio-Techne supplies research and clinical tools for life sciences, including recombinant proteins, antibodies, assays, instruments and diagnostic reagents. Through brands such as R&D Systems, Novus Biologicals and ProteinSimple, it serves academic labs, biopharma R&D and clinical diagnostics. Its portfolio spans discovery reagents to automated analytical systems used in protein and cell analysis.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 316.2 | — | 22.6 | — |
| Q2 2025 | 317 | — | -17.7 | — |
| Q3 2025 | 286.6 | — | 38.2 | — |
| Q4 2025 | 295.9 | — | 38 | — |
| Q1 2026 | 311.4 | -1.5% | 51 | 126% |
| Q2 2026 | 321.2 | 1.3% | 54.6 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: lululemon athletica inc. (LULU), Chime Financial, Inc. (CHYM), Repligen Corporation (RGEN), Li Auto Inc. (LI), Texas Roadhouse, Inc. (TXRH), The Cooper Companies, Inc. (COO)